Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon(Brigham and Women's Hospital), Subodh Verma(St. Michael's Hospital), Sanjiv J. Shah(Northwestern University), Clara Saldarriaga(British Heart Foundation), Mark C. Petrie(British Heart Foundation), Cândida Fonseca, José Francisco Kerr Saraiva(British Heart Foundation), Changsheng Ma(Second Hospital of Shandong University), Heikki Ukkonen(British Heart Foundation), Orly Vardeny(University of Minnesota), Johann Bauersachs(Medizinische Hochschule Hannover), Pardeep S. Jhund(Copenhagen University Hospital), Guillermo Llamas-Esperón(British Heart Foundation), Gerasimos Filippatos(National and Kapodistrian University of Athens), Grzegorz Gajos(British Heart Foundation), John J.V. McMurray(University of Glasgow), Marco A. Alcocer‐Gamba(British Heart Foundation), Morten Schou(British Heart Foundation), Alasdair D Henderson(British Heart Foundation), Felipe A. Martínez(Universidad Nacional de Córdoba), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Gerard C.M. Linssen(British Heart Foundation), Bertram Pitt(Bayer (Germany)), Brian Claggett(Brigham and Women's Hospital), Mikhail Kosiborod(AstraZeneca (Brazil)), Richard W. Troughton(Canterbury Health Laboratories), J. Atherton(Royal Women's Hospital), Savina Nodari(British Heart Foundation), Seok‐Min Kang(Harvard University), Kavita Sharma(British Heart Foundation), Muthiah Vaduganathan(Brigham and Women's Hospital), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Carolyn S.P. Lam(University of Glasgow), Imran Zainal Abidin(British Heart Foundation), Gustavs Latkovskis(British Heart Foundation), Vojtěch Melenovský(Institute for Environmental Policy), Tzvetana Katova(Copenhagen University Hospital), Adriaan A. Voors(University Medical Center Groningen), Vijay Chopra(Max Super Speciality Hospital), Chern‐En Chiang(National Yang Ming Chiao Tung University), Jacob A. Udell(University Health Network), Béla Merkely(Semmelweis University), Naoki Sato(British Heart Foundation), Alex Pui‐Wai Lee(Chinese University of Hong Kong), Akshay S. Desai(British Heart Foundation), Michele Senni(British Heart Foundation), Eva Gonçalvesová(British Heart Foundation), Josep Comin-Colet(British Heart Foundation), Sorel Goland(British Heart Foundation)
Cited by 693
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k